Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity.

bioRxiv : the preprint server for biology·2026
Same author

Hypoxia-induced m<sup>6</sup>A demethylation promotes hepatocellular carcinoma progression by preventing the degradation of Gal-1 mRNA.

Genes & diseases·2026
Same author

Staged screw removal in external plate fixation for distal tibial fractures: a finite element study on adaptive biomechanics.

Scientific reports·2026
Same author

Inhibition of chemokine CXCL12 modulates the tumor microenvironment in glioblastoma and potentiates immune checkpoint inhibitor efficacy in a tissue-specific manner.

Neuro-oncology advances·2026
Same author

Data-driven differentiation analysis of urban high-tech industries: Research on bibliometrics and large language models.

PloS one·2026
Same author

UBE2S emerges as a key driver in an NK cell-based prognostic model for clear cell renal cell carcinoma.

PloS one·2026

Related Experiment Video

Updated: Jun 6, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Predicting in vitro drug sensitivity using Random Forests.

Gregory Riddick1, Hua Song, Susie Ahn

  • 1Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. riddickgp@mail.nih.gov

Bioinformatics (Oxford, England)
|December 8, 2010
PubMed
Summary
This summary is machine-generated.

This study introduces a new Random Forest algorithm to predict drug sensitivity in cell lines using gene expression data. The method accurately forecasts drug responses, outperforming previous techniques.

Related Experiment Videos

Last Updated: Jun 6, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Area of Science:

  • Computational biology
  • Bioinformatics
  • Genomics

Background:

  • Cell line panels like NCI-60 are crucial for evaluating drug candidates' anti-proliferative effects.
  • Previous predictive models for in vitro drug sensitivity relied on gene expression microarrays.
  • Existing statistical models predict drug response for cell lines beyond the initial NCI-60 panel.

Purpose of the Study:

  • To develop an improved algorithm for predicting drug response using gene expression data.
  • To build robust regression models for drug sensitivity prediction.
  • To leverage Random Forest for enhanced predictive accuracy.

Main Methods:

  • A novel multistep algorithm was developed.
  • Random Forest, an ensemble method based on Classification and Regression Trees (CART), was employed.
  • The algorithm builds regression models to predict drug response.

Main Results:

  • The developed method successfully predicted drug response in panels of Breast Cancer and Glioma cell lines.
  • This approach demonstrated superior performance compared to methods based on differential gene expression.
  • The algorithm shows general utility for relating gene expression data to continuous output variables.

Conclusions:

  • The novel Random Forest-based algorithm effectively predicts in vitro drug sensitivity.
  • This method offers improved accuracy and broader applicability than existing techniques.
  • The associated software package 'ivDrug' will be publicly available for further research.